Publications by authors named "Jenniffer Anga"

Article Synopsis
  • * To address this, the country implemented the WHO Reaching Every District (RED) approach, enhancing supervision, monitoring, and data use to boost immunization efforts between July and September 2022.
  • * As a result, immunization coverage significantly increased in both provinces, leading to a nationwide expansion of the WHO RED approach; supportive supervision and data-driven decision-making were key to restoring coverage and will be crucial for sustaining improvements.
View Article and Find Full Text PDF

Addressing vaccine management bottlenecks, including high vaccine wastage rates, has traditionally been addressed through health worker training and other didactic methods of technical assistance or support as required. It has been shown, though, that the high level of technical skills, expertise, and responsibility required in vaccine handling and management cannot be achieved by mere didactic learning. While gains have been made in vaccine management and handling with these approaches, there remain challenges of high vaccine wastage rates and poor vaccine management practices across the board.

View Article and Find Full Text PDF

The Western Pacific Region (WPR) established a goal to decrease chronic hepatitis B virus (HBV) infection among children to <1% and to achieve ≥95% hepatitis B vaccine birth dose (HepB-BD) and ≥95% three-dose (HepB3) coverage by 2017. In 2016, we conducted a national serosurvey in the Solomon Islands among 6-7-year-old school children to assess progress towards the control goal and immunity to measles, rubella, tetanus and diphtheria. Eighty schools were selected systematically proportional to their 6-7-year-old population; all 6-7-year-olds were enrolled.

View Article and Find Full Text PDF

Monovalent Hepatitis B vaccine (HepB) is heat stable, making it suitable for storage outside cold chain (OCC) at 37°C for 1month. We conducted an OCC project in the Solomon Islands to determine the feasibility of and barriers to national implementation and to evaluate impact on coverage. Healthcare workers at 13 facilities maintained monovalent HepB birth dose (HepB-BD) OCC for up to 28days over 7months.

View Article and Find Full Text PDF